Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 4 Planned sale President and CEO sold 1,299 shares at $9.60 ($12,470)
  2. 4 Planned sale President and CEO sold 44,121 shares at $8.00 ($352,968)
  3. 4 Planned sale Chief Financial Officer sold 2,566 shares at $8.00 ($20,528)
  4. 4 Planned sale Chief Financial Officer sold 55 shares at $7.70 ($424)
  5. 4 Planned sale President and CEO sold 1,302 shares at $5.81 ($7,565)
  6. 4 Planned sale President and CEO sold 20,871 shares at $4.18 ($87,241)
  7. 4 Planned sale Chief Financial Officer sold 4,089 shares at an average $4.18 ($17,089)
  8. 4 Grant or award Director acquired 108,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Director acquired 36,000 shares (grant or award)
  11. 4 Grant or award Director acquired 36,000 shares (grant or award)
  12. 4 Grant or award Director acquired 36,000 shares (grant or award)
  13. 4 Grant or award Director acquired 36,000 shares (grant or award)
  14. 4 Grant or award Director acquired 36,000 shares (grant or award)
  15. 4 Grant or award Director acquired 36,000 shares (grant or award)
  16. 4 Grant or award Director acquired 36,000 shares (grant or award)
  17. 4 Planned sale President and CEO sold 806 shares at $5.82 ($4,691)
  18. 4 Grant or award Chief Financial Officer acquired 57 shares (grant or award)
  19. 4 Planned sale President and CEO sold 970 shares at $6.69 ($6,489)
  20. 4 Grant or award Chief Financial Officer acquired 16,665 shares (grant or award)

Page 1 of 27 · 526 filings